Personalis (NASDAQ:PSNL - Get Free Report) will likely be posting its Q2 2025 quarterly earnings results after the market closes on Tuesday, August 5th. Analysts expect Personalis to post earnings of ($0.25) per share and revenue of $20.12 million for the quarter. Personalis has set its FY 2025 guidance at EPS and its Q2 2025 guidance at EPS.
Personalis (NASDAQ:PSNL - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported ($0.18) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.05. The company had revenue of $20.61 million during the quarter, compared to analyst estimates of $17.41 million. Personalis had a negative net margin of 98.10% and a negative return on equity of 48.78%. On average, analysts expect Personalis to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Personalis Stock Down 1.6%
Shares of NASDAQ:PSNL traded down $0.09 during trading on Friday, reaching $5.39. 853,203 shares of the company traded hands, compared to its average volume of 1,038,599. The firm has a fifty day simple moving average of $6.06 and a 200 day simple moving average of $4.92. The firm has a market cap of $476.04 million, a P/E ratio of -4.18 and a beta of 1.86. Personalis has a 1-year low of $2.81 and a 1-year high of $7.79.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. Needham & Company LLC reissued a "buy" rating and set a $7.00 target price on shares of Personalis in a research note on Thursday, April 10th. Guggenheim began coverage on shares of Personalis in a research note on Thursday, May 15th. They issued a "buy" rating and a $6.00 price objective for the company. Finally, HC Wainwright lifted their price objective on shares of Personalis from $8.00 to $9.00 and gave the company a "buy" rating in a research note on Wednesday, May 7th. Six analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $7.67.
Get Our Latest Stock Report on Personalis
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the company. Focus Partners Wealth bought a new position in shares of Personalis during the 1st quarter worth about $47,000. Dynamic Technology Lab Private Ltd increased its holdings in shares of Personalis by 75.6% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 76,729 shares of the company's stock worth $269,000 after purchasing an additional 33,044 shares during the period. Royal Bank of Canada increased its holdings in shares of Personalis by 3.2% during the 1st quarter. Royal Bank of Canada now owns 78,341 shares of the company's stock worth $275,000 after purchasing an additional 2,395 shares during the period. Finally, Goldman Sachs Group Inc. increased its stake in Personalis by 55.7% in the first quarter. Goldman Sachs Group Inc. now owns 284,426 shares of the company's stock valued at $998,000 after acquiring an additional 101,706 shares during the period. Institutional investors own 61.91% of the company's stock.
Personalis Company Profile
(
Get Free Report)
Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.
Featured Stories
Before you consider Personalis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Personalis wasn't on the list.
While Personalis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access